β-Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study.
Publishing year: 2015
Publication/Series: Journal of the American Heart Association
Document type: Journal article
Patients with myocardial infarction (MI) and concomitant chronic obstructive pulmonary disease (COPD) constitute a high-risk group with increased mortality. β-Blocker therapy has been shown to reduce mortality, prevent arrhythmias, and delay heart failure development after an MI in broad populations. However, the effect of β-blockers in COPD patients is less well established and they may also be less treated due to fear of adverse reactions. We investigated β-blocker prescription at discharge in patients with COPD after MI.
- Cardiac and Cardiovascular Systems
- ISSN: 2047-9980
E-mail: gustav [dot] smith [at] med [dot] lu [dot] se